Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
| Status: | Completed |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 1/27/2018 |
| Start Date: | June 2005 |
| End Date: | January 1, 2018 |
The objective of this study is to identify and maintain a registry of well-characterized
limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be
candidates for future treatment trials based on their defined genetic classification of LGMD.
In the course of this study, the investigators will perform a muscle biopsy and DNA testing
in an unlimited number of patients with clinically diagnosed LGMD. The genetic testing will
be extended to the family of the study subject in order to better understand true genetic
defect.
limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be
candidates for future treatment trials based on their defined genetic classification of LGMD.
In the course of this study, the investigators will perform a muscle biopsy and DNA testing
in an unlimited number of patients with clinically diagnosed LGMD. The genetic testing will
be extended to the family of the study subject in order to better understand true genetic
defect.
Inclusion Criteria:
- any subject with clinical diagnosis of LGMD
- must visit Columbus Children's Hospital for 2-day study visit
- muscle biopsy tissue must be available; either from previous biopsy, affected
relative, or willing to have biopsy at Columbus Children's
Exclusion Criteria:
- diagnosis of a neuromuscular disorder other than LGMD
- unable to provide muscle tissue from previous or current biopsy
- incapable of giving consent and not having a legal guardian willing or able to do so
We found this trial at
1
site
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
Click here to add this to my saved trials
